ArticleJHEP reports : innovation in hepatology2026
Odevixibat treatment for recurrent cholestasis in a patient with biallelic UNC45A variants causing osteo-oto-hepato-enteric syndrome.
Floris Imhann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.